MRP 68/-STRIP

Composition

Each uncoated bilayered tablet contains: Glimepride IP 1mg + Metformin Hydochloride Ip 500mg (In sustained Release From) Excipients q.s (DOUBLE COLOR)

Doses

As Directed by Physician

Description

Glimepiride IP 1mg + Metformin Hydrochloride IP 500mg (in sustained release form) is a combination medication primarily used to treat type 2 diabetes by effectively controlling high blood sugar levels; it works by stimulating the pancreas to produce more insulin (via glimepiride) while simultaneously decreasing the liver's glucose production and improving insulin sensitivity (via metformin), making it a potent treatment option when taken as directed with a proper diet and exercise regimen. 

Formulation

Tablet